(Q30420271)

English

Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

multicenter clinical trial

0 references

author name string

Mathieu Peeters

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Stefan Regner

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Tejaswini Vaman

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Jeanne-Marie Devaster

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Lars Rombo

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

9 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

6483-6491

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Pandemic potential of a strain of influenza A (H1N1): early findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

A new decade, a new seasonal influenza: the Council of the European Union Recommendation on seasonal influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Immunogenicity profile of a 3.75-μg hemagglutinin pandemic rH5N1 split virion AS03A-adjuvanted vaccine in elderly persons: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Response to a monovalent 2009 influenza A (H1N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Effect on cellular and humoral immune responses of the AS03 adjuvant system in an A/H1N1/2009 influenza virus vaccine administered to adults during two randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.081

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2012.07.081

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30420271&oldid=1982340209"